1. ScholarBank@NUS

Soo Chin Lee

rp01836

Collaboration Map View Statistics Email Alert RSS Feed

Profile

Full Name
Soo Chin Lee
Variants
Lee, S.C
Lee, S.C.
Lee, Soo Chin
Lee, S.-C.
 
Main Affiliation
 
Faculty
 
Email
csilsc@nus.edu.sg
 
Other emails
 

Publications

Refined By:
Department:  MEDICINE

Results 61-80 of 106 (Search time: 1.165 seconds).

Issue DateTitleAuthor(s)
6114-Aug-2020Integration of antiangiogenic therapy with cisplatin and gemcitabine chemotherapy in patients with nasopharyngeal carcinoma.Chong, Wan Qin; Lim, Chwee Ming ; Sinha, Arvind Kumar ; Tan, Chee Seng ; Chan, Gloria Hui Jia; Huang, Yiqing; Barr Kumarakulasinghe, Nesaretnam; Sundar, Raghav ; Jeyasekharan, Anand D ; Loh, Woei Shyang ; Tay, Joshua K. ; Yadav, Kritika ; Wang, Lingzhi ; Wong, Andrea L. ; Kong, Li Ren ; Soo, Ross Andrew ; Lau, Jieying Amelia ; Soon, Yu Yang ; Goh, Robby Miguel; Ho, Francis Cho Hao ; Chong, Siew Meng ; Lee, Soo-Chin ; Loh, Kwok Seng ; Tai, Bee Choo ; Lim, Yaw Chyn ; Goh, Boon Cher 
62Feb-2013Interest and attitudes of patients, cancer physicians, medical students and cancer researchers towards a spectrum of genetic tests relevant to breast cancer patientsNgoi, N.; Lee, S.-C. ; Hartman, M. ; Khin, L.-W.; Wong, A.
63Aug-2011Is the c.3G>C mutation in the succinate dehydrogenase subunit D (SDHD) gene due to a founder effect in Chinese head and neck paraganglioma patients?Zha, Y.; Chen, X.-M.; Lam, C.-W.; Lee, S.-C. ; Tong, S.-F.; Gao, Z.-Q.
64Apr-2006Ketoconazole renders poor CYP3A phenotype status with midazolam as probe drugTham, L.-S.; Lee, H.-S.; Wang, L. ; Yong, W.-P. ; Fan, L.; Ong, A.-B.; Sukri, N.; Soo, R. ; Lee, S.-C. ; Goh, B.-C.
651-Dec-2007Lack of association of single-nucleotide polymorphisms in pregnane X receptor, hepatic nuclear factor 4α, and constitutive androstane receptor with docetaxel pharmacokineticsTham, L.-S.; Holford, N.H.G.; Hor, S.-Y.; Tan, T. ; Wang, L. ; Lim, R.-C.; Lee, H.-S.; Lee, S.-C. ; Goh, B.-C.
662009Lack of somatic mutations in VEGFR-2 tyrosine kinase domain in hepatocellular carcinomaChuah, B.Y.S.; Yeo, W.-L. ; Guo, J.Y. ; Lim, S.-G.; Yap, H.-L. ; Goh, B.-C.; Lee, S.-C. 
672017Limb hypothermia for preventing paclitaxel-induced peripheral neuropathy in breast cancer patients: A pilot studySundar, R ; Bandla, A ; Tan, S.S.H ; Liao, L.-D ; Kumarakulasinghe, N.B; Jeyasekharan, A.D ; Ow, S.G.W; Ho, J; Tan, D.S.P; Lim, J.S.J ; Vijayan, J; Therimadasamy, A.K; Hairom, Z; Ang, E; Ang, S; Thakor, N.V ; Lee, S.-C ; Wilder-Smith, E.P.V 
6819-Feb-2019Low-dose anti-inflammatory combinatorial therapy reduced cancer stem cell formation in patient-derived preclinical models for tumour relapse preventionKhoo, Bee Luan; Grenci, Gianluca ; Lim, Joey Sze Yun; Lim, Yan Ping ; Fong, July; Yeap, Wei Hseun; Lim, Su Bin; Chua, Song Lin; Wong, Siew Cheng ; Yap, Yoon-Sim ; Lee, Soo Chin ; Lim, Chwee Teck ; Han, Jongyoon
6928-Jun-2023Macrophage IL-1 & beta; contributes to tumorigenesis through paracrine AIM2 inflammasome activation in the tumor microenvironmentChew, Zhi Huan ; Cui, Jianzhou ; Sachaphibulkij, Karishma ; Tan, Isabelle ; Kar, Shreya; Koh, Kai Kiat; Singh, Kritika; Lim, Hong Meng ; Lee, Soo Chin ; Kumar, Alan Prem ; Gasser, Stephan ; Lim, Lina HK 
7015-Feb-2009Pharmacodynamic effects of seliciclib, an orally administered cell cycle modulator, in undifferentiated nasopharyngeal cancerHsieh, W.-S. ; Soo, R. ; Pen, B.-K.; Loh, T.; Dong, D.; Son, D.; Wong, L.-S.; Green, S.; Chiao, J.; Cui, C.-Y.; Lai, Y.-F.; Lee, S.-C. ; Mow, B.; Soong, R.; Salto-Tellez, M.; Goh, B.-C.
7129-Nov-2018Pharmacogenomic Prediction of Bleomycin-Induced Pneumonitis in South East Asian Hodgkin Lymphoma PatientsLee, Joanne Shu Xian ; Poon, Li Mei; Liu, Xin; Yuen, Yi Ching; Somasundaram, Nagavalli ; Chin, Suk Teng; Teoh, Chia Meng ; Yan, Benedict; Chan, Hian Li Esther ; Chee, Yen-Lin ; Tang, Tiffany ; Farzana, Noorul; Aw, Caroline Hui Ting; Khor, Chiea Chuen ; Ngeow, Joanne Yuen Yie; Ong, Choon Kiat ; Tai, E Shyong ; Chng, Wee Joo ; Goh, Boon Cher ; Lee, Soo Chin ; Aminkeng, Folefac 
72Jun-2012Pharmacologic modulation strategies to reduce dose requirements of anticancer therapy while preserving clinical efficacyZee, Y.-K.; Goh, B.-C.; Lee, S.-C. 
732015Phase I and biomarker study of OPB-51602, a novel signal transducer and activator of transcription (STAT) 3 inhibitor, in patients with refractory solid malignanciesWong, Andrea; Soo, Ross A.; Tan, Daniel; Lee, Soo Chin ; Lim, Joline S J; Marban, P.C.; Kong, Li Ren ; Lee, Youngjoo; Wang, Lingzhi ; Thuya, Win Lwin ; Soong, R.; Yee, M.Q.; Chin, T.M.; Cordero, Maricel Tiemsim; Asuncion, Bernadette Reyna ; Pang, B.; Pervaiz, Shazib ; Hirpara, Jayshree L. ; Sinha, Arvind; Xu, W.W.; Yuasa, M.; Tsunoda, T.; Motoyama, M.; Yamauchi, T.; Goh, Boon Cher 
74Nov-2011Phase I and pharmacodynamic study of an orally administered novel inhibitor of histone deacetylases, SB939, in patients with refractory solid malignanciesYong, W.P. ; Goh, B.C.; Soo, R.A. ; Toh, H.C.; Ethirajulu, K.; Wood, J.; Novotny-Diermayr, V.; Lee, S.C. ; Yeo, W.L. ; Chan, D.; Lim, D.; Seah, E.; Lim, R.; Zhu, J.
751-Aug-2003Phase I trial of fixed dose-rate gemcitabine in combination with carboplatin in chemonaive advanced non-small-cell lung cancer: A Cancer Therapeutics Research Group studySoo, R.A. ; Lim, H.L.; Wang, L.Z. ; Lee, H.S.; Millward, M.J.; Tok, L.T.; Lee, S.C. ; Lehnert, M.; Goh, B.C.
7623-Feb-2022Phase Ib Dose-Finding Study of Varlitinib Combined with Weekly Paclitaxel With or Without Carboplatin +/- Trastuzumab in Advanced Solid TumorsLee, Matilda Xinwei; Wong, Andrea LA ; Ow, Samuel; Sundar, Raghav ; Tan, David SP ; Soo, Ross A ; Chee, Cheng Ean ; Lim, Joline SJ ; Yong, Wei Peng ; Lim, Siew Eng; Goh, Boon Cher ; Wang, Lingzhi ; Lee, Soo Chin 
771-Jun-2022Phase Ib/II Dose Expansion Study of Lenvatinib Combined with Letrozole in Postmenopausal Women with Hormone Receptor–Positive Breast CancerLim, JSJ ; Wong, ALA ; Ow, SGW ; Ngoi, NYL ; Chan, GHJ; Ang, YLE; Chong, WQ; Lim, SE ; Lim, YW; Lee, M; Choo, JRE; Tan, HL; Yong, WP ; Soo, RA ; Tan, DSP ; Chee, CE ; Sundar, R ; Yadav, K ; Jain, S ; Wang, L ; Tai, BC ; Goh, BC ; Lee, SC 
782016Phase Ib/II randomized, open-label study of doxorubicin and cyclophosphamide with or without low-dose, short-course sunitinib in the pre-operative treatment of breast cancerWong A.L.A. ; Sundar R.; Wang T.-T. ; Ng T.-C. ; Zhang B. ; Tan S.-H. ; Soh T.I.P.; Pang A.S.L.; Tan C.-S.; Ow S.G.W.; Wang L. ; Mogro J.; Ho J.; Jeyasekharan A.D. ; Huang Y.; Thng C.-H. ; Chan C.-W. ; Hartman M. ; Iau P.; Buhari S.A. ; Goh B.-C. ; Lee S.-C. 
79Dec-2010Phase II study of gemcitabine and carboplatin in metastatic breast cancers with prior exposure to anthracyclines and taxanesChan, D.; Yeo, W.-L. ; Tiemsim Cordero, M.; Wong, C.-I.; Chuah, B.; Soo, R. ; Tan, S.-H.; Lim, S.-E.; Goh, B.-C.; Lee, S.-C. 
80May-2010Phase III randomized trial of sunitinib versus capecitabine in patients with previously treated HER2-negative advanced breast cancerBarrios, C.H.; Liu, M.-C.; Lee, S.C. ; Vanlemmens, L.; Ferrero, J.-M.; Tabei, T.; Pivot, X.; Iwata, H.; Aogi, K.; Lugo-Quintana, R.; Harbeck, N.; Brickman, M.J.; Zhang, K.; Kern, K.A.; Martin, M.